(Q37451558)

20 August 2017

1 reference

title

Epigenetic biomarkers in urothelial bladder cancer (English)

1 reference

20 August 2017

0 references

Wun-Jae Kim

1

1 reference

PubMed ID

19379084

20 August 2017

Yong-June Kim

series ordinal

2

1 reference

20 August 2017

1 April 2009

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

20 August 2017

1 reference

20 August 2017

9

1 reference

20 August 2017

259-269

1 reference

20 August 2017

3

1 reference

20 August 2017

Cancer statistics, 2001

1 reference

Asymmetric distribution of oncogene products at mitosis

21 January 2018

1 reference

Clinical implications of the p53 tumor-suppressor gene

21 January 2018

1 reference

Molecular biology of transitional cell carcinoma

21 January 2018

1 reference

Worms gang up on bacteria

21 January 2018

1 reference

Cancer epigenetics comes of age

21 January 2018

1 reference

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

21 January 2018

The Hallmarks of Cancer

1 reference

Two genetic hits (more or less) to cancer

21 January 2018

1 reference

Spreading of methylation within RUNX3 CpG island in gastric cancer

21 January 2018

1 reference

Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients.

21 January 2018

1 reference

Molecular biomarkers in urothelial bladder cancer

21 January 2018

1 reference

Methylation of neutral endopeptidase 24.11 promoter in rat hepatocellular carcinoma

21 January 2018

1 reference

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

21 January 2018

1 reference

Genetic unmasking of an epigenetically silenced microRNA in human cancer cells

21 January 2018

1 reference

RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.

21 January 2018

1 reference

Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor

21 January 2018

1 reference

Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients

21 January 2018

1 reference

Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection

21 January 2018

1 reference

Hypomethylation distinguishes genes of some human cancers from their normal counterparts

21 January 2018

1 reference

5-Methylcytosine as an Endogenous Mutagen in the Human LDL Receptor and p53 Genes

21 January 2018

1 reference

Epigenetics in human disease and prospects for epigenetic therapy

21 January 2018

1 reference

DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis

21 January 2018

1 reference

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

21 January 2018

1 reference

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

21 January 2018

1 reference

A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer

21 January 2018

1 reference

Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.

21 January 2018

1 reference

p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?

21 January 2018

1 reference

p53 nuclear immunoreactivity as a predictor of response and outcome following chemotherapy for metastatic bladder cancer

21 January 2018

1 reference

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.

21 January 2018

1 reference

Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel

21 January 2018

1 reference

Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.

21 January 2018

1 reference

Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma.

21 January 2018

1 reference

High-throughput DNA methylation profiling using universal bead arrays

21 January 2018

1 reference

The power and the promise of DNA methylation markers

21 January 2018

1 reference

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis

21 January 2018

1 reference

Promoter hypermethylation identifies progression risk in bladder cancer.

21 January 2018

1 reference

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays

21 January 2018

1 reference

Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals

21 January 2018

1 reference

Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer.

21 January 2018

1 reference

Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.

21 January 2018

1 reference

CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer

21 January 2018

1 reference

Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes

21 January 2018

1 reference

Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection

21 January 2018

1 reference

Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia.

21 January 2018

1 reference

Molecular detection of prostate cancer: a role for GSTP1 hypermethylation

21 January 2018

1 reference

Evaluation and follow-up strategies for superficial bladder cancer.

21 January 2018

1 reference

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers

21 January 2018

1 reference

Urothelial cancer biomarkers for detection and surveillance

21 January 2018

1 reference

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

21 January 2018

1 reference

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

21 January 2018

1 reference

21 January 2018

Epigenetics in cancer

1 reference

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis

21 January 2018

1 reference

Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis

21 January 2018

1 reference

Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses

21 January 2018

1 reference

Cancer epigenomics: DNA methylomes and histone-modification maps

21 January 2018

1 reference

Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer.

21 January 2018

1 reference

p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.

21 January 2018

1 reference

Suppression of intestinal neoplasia by DNA hypomethylation.

21 January 2018

1 reference

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

21 January 2018

1 reference

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies

21 January 2018

1 reference

Histone deacetylases and cancer: causes and therapies

21 January 2018

1 reference

Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung Cancer

21 January 2018

1 reference

Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERM.09.5

1 reference

20 August 2017

1 reference

PubMed ID

19379084